PureTech Health plc (OTCMKTS:PTCHF) Short Interest Down 32.0% in August

PureTech Health plc (OTCMKTS:PTCHF) was the recipient of a large decline in short interest in August. As of August 31st, there was short interest totalling 16,800 shares, a decline of 32.0% from the August 15th total of 24,700 shares. Based on an average trading volume of 3,300 shares, the short-interest ratio is presently 5.1 days.

PureTech Health Stock Performance

Shares of PureTech Health stock remained flat at $1.90 during trading on Monday. PureTech Health has a twelve month low of $1.69 and a twelve month high of $3.00. The company has a 50-day simple moving average of $2.13 and a two-hundred day simple moving average of $2.49.

PureTech Health Company Profile

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.